The uncropped and unprocessed scans are provided in the Source Data file
As expected, GLP-1R agonism resulted in a reduced intake of both control liquid and ethanol diets, and a corresponding reduction of body weight in both the control and ethanol groups (Supplementary Fig
Medications such as Ozempic and Wegovy are typically prescribed at higher doses for obesity treatment than for diabetes care, and further studies are needed to determine whether the same genetic factors influence weight-loss outcomes
[29] For women using opioids for chronic pain, consider strategies to avoid or minimize the use of opioids, including alternative pain therapies (i.e., nonpharmacologic) and nonopioid pharmacologic treatments
In conjunction with a variety of associated proteins, integrin heterodimers function as signaling hubs, mediating both inside-out and outside-in signal transduction 3,4,5
This FDA-approved medication redefines how weight management is approached by targeting two key hormones: GLP-1 and GIP